UBS Raises Nutrien (NTR) Price Target to $62
Key Points
- UBS increased its price target for Nutrien Ltd. from $59 to $62, keeping a Sell rating.
- As of October 27, 2026, Nutrien shares recently traded at $68.22, about 1.7% below the event day's close of $69.37.
- The average price target among analysts for Nutrien is $77.31, indicating potential upside from current levels.
Get Nutrien Ltd. text alerts
We text you when insiders, Congress, analysts or big funds move on $NTR.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Nutrien Ltd. alert may contain errors. Disclosures
On October 27, 2026, UBS raised its price target on Nutrien Ltd. (NTR) to $62 from $59 while keeping a Sell rating. This update comes as analysts assess the company's performance and market conditions. The information is based on UBS's research note from the same day.
NTR
Nutrien Ltd.
UBS vs. the S&P 500
Hypothetical returns from UBS's disclosed trades, not real profit or advice. How we model this.
UBS's Call on Nutrien Ltd.
UBS's upgraded target reflects its ongoing evaluation of Nutrien's market position. The firm has maintained a Sell rating, suggesting it expects the stock to underperform in the near term. The new target represents a cautious view on Nutrien's prospects despite the slight increase from the previous target.
Other Institutional Activity in Nutrien Ltd.
Several other institutional investors have been active in Nutrien Ltd. Recently, Royal Bank of Canada grew its holdings by 1,888,437 shares, ending with 32,897,258 shares valued at approximately $2.28 billion. Bank of Montreal also increased its position by 913,492 shares, bringing its total to 13,797,719 shares worth about $957.1 million. Deutsche Bank AG added 817,612 shares, totaling 9,352,182 shares with a value of around $648.8 million.
Nutrien Ltd. Stock Holds Steady
As of October 27, 2026, Nutrien shares closed at $69.37. The stock recently traded at $68.22, which is about 1.7% below the closing price. Nutrien's stock is currently trading 20.1% below its 52-week high of $85.36, but 28.6% above its 52-week low of $53.03. This suggests the stock is positioned closer to its lower range.
$NTR price target
Nutrien Ltd. daily closes and this analyst's $62 target. Not advice.
Recent Earnings
Nutrien reported trailing twelve-month (TTM) revenue of approximately $27.29 billion, with a TTM earnings per share (EPS) of $4.94. The company is set to announce its next earnings on November 4, 2026. Nutrien has shown a revenue growth of 4.0% year-over-year and a net margin of 8.7%, reflecting its operational efficiency.
Dividend
Nutrien Ltd. pays an annual dividend of $2.20 per share, which translates to a yield of 3.22%. The company's dividend payout ratio stands at 44.3%, indicating a balanced approach to returning value to shareholders while retaining earnings for growth.
Analysts Set New Price Targets
On October 27, 2026, UBS maintained a Sell rating on Nutrien with a new price target of $62, up from $59. Meanwhile, Freedom Broker initiated coverage with a Hold rating and a target of $78. The average price target among analysts for Nutrien is currently $77.31, based on 22 opinions, indicating a consensus Buy recommendation.
About Nutrien Ltd.
Nutrien Ltd. is a leading provider of crop inputs and services, operating through segments like Retail, Potash, Nitrogen, and Phosphate. The company markets various agricultural products and offers agronomic services. This recent target adjustment by UBS reflects ongoing assessments of the agricultural sector's dynamics and Nutrien's strategic positioning.
Bottom Line
Investors should keep an eye on Nutrien's upcoming earnings report on November 4, 2026, as well as any further analyst updates. UBS's cautious stance with a Sell rating and a raised target highlights the mixed outlook among analysts regarding Nutrien's performance in the current market environment.
Related Filing Alerts
Source: UBS's rating change on $NTR (Oct 27, 2026). Written by software, not financial advice. How we make alerts